On WADA's 2026 Prohibited List, BPC-157 falls under S0 (Non-Approved Substances), while TB-500 falls under S2, the peptide hormones and growth factors section
Peptide blends involve questions about safety, sourcing, candidacy, dosing, treatment timing, and follow-up
Zom RL 1 , van Baal J, Goselink RM, Bakker JA, de Veth MJ, van Vuuren AM
You still have to put in some work too
[21] When treated with cyanocobalamin, patients with Leber's disease may develop serious optic atrophy, possibly leading to blindness, based on few case reports
All mice received 2 days of 10 mL/kg body weight sterile saline subcutaneous injections before beginning the treatment phase to allow for acclimation to the handling and stress associated with injections